RxDoctor Payments Data

Brian Larkin, MD

Body Imaging · Robbinsdale, MNNPI 1336149467

Payments from drug & device makers

$186,201in general payments, 2019–2025

Across 158 payments — averaging $1178.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$122K
  • Boston Scientific$33K
  • Microvention, Inc.$28K
  • Medtronic$2K
  • W. L. Gore & Associates, Inc.$145
  • Venclose Inc.$90
  • plus $127 from 3 others
$77,025in research payments, 2019–2025

Across 40 payments — averaging $1925.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$71K
  • Microvention, Inc.$6K

What the payments were for

  • Consulting fees$185,341100%
  • Food & beverage$8610%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott111$122,423
Boston Scientific15$32,658
Microvention, Inc.23$28,450
Medtronic3$2,309
W. L. Gore & Associates, Inc.1$145
Venclose Inc.1$90
Silk Road Medical, Inc.1$57
Angiodynamics, Inc.2$45
United Imaging Healthcare North America LLC1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few body imaging providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$78,262
Medicare patients
726
Services billed
2,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin11$29

Paid to pharmacies, not to this prescriber.

Other body imaging in Robbinsdale

Where these figures come from

Is this you, or does something look wrong? →